Finance

Lists
Why is SOPH up 5.29%?
Dive Deeper
SOPH:NASDAQ
Sophia Genetics SA
$7.86
+5.29%
(+0.39) 1D
$8.29
+5.51% (+0.43)
After hours
Closed: Nov 12, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SOPH...
Open
$7.31
High
$7.96
Low
$7.22
Mkt. cap
672.82M
Avg. vol.
679.46K
Volume
732.91K
52-wk high
$8.98
52-wk low
$3.83
EPS
-$1.09
Beta
1.09
Shares outstanding
85.13M
No. of employees
415
Open
$7.31
High
$7.96
Low
$7.22
Mkt. cap
672.82M
Avg. vol.
679.46K
Volume
732.91K
52-wk high
$8.98
52-wk low
$3.83
EPS
-$1.09
Beta
1.09
Shares outstanding
85.13M
No. of employees
415
News stories
From web sources and news partners
Profile
Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions. Wikipedia
About Sophia Genetics SA
CEOJurgi Camblong
Employees415
FoundedJan 1, 2011
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to SOPH in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SOPH in the last 3 months.
Highest
Current $7.86
$14.00 (+78.12%)
Average
$11.50 (+46.31%)
Lowest
$9.00 (+14.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$14.00
+78.1%
11/05/2026
Mark Massaro
BTIG
Buy
Reiterated
$9.00
+14.5%
11/03/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
09/25/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$7.00
-10.9%
08/04/2026
Daniel Brennan
TD Cowen
Buy
Maintained
-
-
08/04/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
$7.00
-10.9%
05/06/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
-$0.12 / -$0.20
+39.30%beat
Revenue / Est. (USD)
24.27M / 24.03M
+0.98%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
21.71M
21.69M
23.31M
24.27M
Cost of goods sold
7.02M
6.94M
8.25M
8.33M
Cost of revenue
7.02M
6.94M
8.25M
8.33M
Research and development expenses
8.54M
9.46M
8.73M
8.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.65M
22.57M
26.39M
25.46M
Operating expense
33.24M
32.03M
35.11M
33.76M
Total operating expenses
40.25M
38.97M
43.36M
42.09M
Operating income
-18.54M
-17.28M
-20.05M
-17.82M
Other non operating income
90.00K
-92.00K
-317.00K
-1.14M
EBT including unusual items
-19.57M
-19.07M
-22.28M
-19.96M
EBT excluding unusual items
-19.60M
-19.07M
-22.28M
-19.96M
Income tax expense
-395.00K
253.00K
78.00K
314.00K
Effective tax rate
2.02%
-1.33%
-0.35%
-1.57%
Other operating expenses
45.00K
-
-5.00K
-
Net income
-19.18M
-19.32M
-22.36M
-20.27M
Net profit margin
-88.35%
-89.09%
-95.91%
-83.54%
Earnings per share
-0.17
-0.19
-0.20
-0.12
Interest and investment income
381.00K
289.00K
231.00K
451.00K
Interest expense
-1.67M
-1.67M
-1.62M
-1.62M
Net interest expenses
-1.29M
-1.38M
-1.39M
-1.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.10M
-16.13M
-18.90M
-16.71M
Gain or loss from assets sale
-
3.00K
-3.00K
-7.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps